Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations

Completed · Not applicable

Conditions studied: Vaccine Preventable Disease

In brief

A cluster randomized trial will be conducted prior to widespread vaccine availability to the general public. Community-informed COVID-19 vaccine messages will be disseminated to participants. At baseline, 2 weeks and 4 weeks, the study team will survey participants to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Key facts

Study ID

NCT04765839

Run by

Mayo Clinic

People needed

74

Starts

2021-02-12

Expected to finish

2021-04-03

Last updated by the study team

2021-07-30

Who can join

Age: 18 and older, up to 101. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Self-identification within a CLs social network
• Age 18 or greater
• Functional internet access.

You may not qualify if…

• Does not self-identify within a CLs social network
• Is under the age of 18
• Does not have functional internet access.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.